2939.30.00.00/Caffeine Sodium Benzoate/Canada

Caffeine Sodium Benzoate from Canada

Double salt combining caffeine with sodium benzoate, used in parenteral migraine treatments. Classified under HTS 2939.30.00.00 as a caffeine salt per Chapter Note 4(C)(1). Supplied as sterile powder for IV solutions.

Duty Rate — Canada → United States

100%

Rate breakdown

9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter

9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter

Calculate with your customs value Verify classification with AI

Import Tips

• Provide certificates for both caffeine and benzoate components; Sterility testing required for injectable use; Benzoate content declaration prevents misclassification